Characteristics and Outcomes of Patients With Diabetes Mellitus Undergoing Peripheral Vascular Intervention for Infrainguinal Symptomatic Peripheral Artery Disease

被引:8
|
作者
Weissler, E. Hope [1 ]
Narcisse, Dennis, I [2 ]
Rymer, Jennifer A. [2 ]
Armstrong, Ehrin J. [3 ]
Secemsky, Eric [4 ]
Gray, William A. [5 ]
Mustapha, Jihad A. [6 ]
Adams, George L. [7 ]
Ansel, Gary M. [8 ]
Patel, Manesh R. [2 ]
Jones, W. Schuyler [2 ]
机构
[1] Duke Univ Hlth Syst, Div Vasc & Endovasc Surg, Durham, NC USA
[2] Duke Univ Hlth Syst, Div Cardiol, Durham, NC USA
[3] Univ Colorado, Sch Med, Div Cardiol, Aurora, CO USA
[4] Beth Israel Deaconess Med Ctr, Div Cardiol, Boston, MA 02215 USA
[5] Lankenau Heart Inst, Main Line Hlth, Wynnewood, PA USA
[6] Adv Cardiac & Vasc Ctr Amputat Prevent, Grand Rapids, MI USA
[7] UNC REX Healthcare, Div Cardiol, Raleigh, NC USA
[8] OhioHealth, Columbus, OH USA
关键词
lower extremity intervention; endovascular intervention; peripheral artery disease; diabetes mellitus; chronic limb threatening ischemia;
D O I
10.1177/1538574420968671
中图分类号
R61 [外科手术学];
学科分类号
摘要
Purpose: Patients with diabetes mellitus (DM) are known to be at higher risk for peripheral artery disease (PAD), amputations, and major adverse cardiovascular events, though it is unclear whether they are at any higher risk for repeat intervention. LIBERTY 360 offered an opportunity to study a real-world cohort of patients who underwent distal superficial femoral artery endovascular revascularizations. We aimed to describe patients with DM, their outcomes following peripheral vascular intervention, and the effect of DM on outcomes in the LIBERTY 360 cohort. Methods: LIBERTY 360 is a prospective, multi-center, non-randomized, mono-industry funded observational study of patients undergoing endovascular revascularization. Outcomes included 30-day and 1-year all-cause mortality, major amputation, target vessel/lesion revascularization, and a composite of those events. A multivariable regression model including DM was constructed to examine the effect of DM on outcomes. Multivariable survival estimates were made using Cox proportional hazards models. Results: A total of 1,204 patients were enrolled, of whom 727 had DM (60.4%). Patients with DM had significantly more comorbidities and a third required insulin for DM management. Patients with DM had more severe disease based on Rutherford classification at baseline. After adjusting for comorbidities and disease severity, DM patients had more frequent major amputations at 1 year (5.2% versus 1.2%; HR 2.71, 95%CI 1.05-6.98, p = 0.040). The 1-year rates of all-cause mortality and target vessel/lesion revascularization were not significantly higher for patients with DM. Conclusions: Diabetes mellitus was associated with increased major amputations at 1 year following endovascular revascularization after accounting for demographics, comorbidities, and PAD-related characteristics. Further research is needed to determine which aspects of PAD and DM are most strongly associated with poor outcomes following lower extremity revascularization.
引用
收藏
页码:124 / 134
页数:11
相关论文
共 50 条
  • [1] Diabetes mellitus and peripheral artery disease
    Takahara, Mitsuyoshi
    DIABETOLOGY INTERNATIONAL, 2025, 16 (01) : 7 - 12
  • [2] Diabetes mellitus and outcomes of lower extremity revascularization for peripheral artery disease
    Bhandari, Nipun
    Newman, Jonathan D.
    Berger, Jeffrey S.
    Smilowitz, Nathaniel R.
    EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES, 2022, 8 (03) : 298 - 306
  • [3] Epidemiology and Risk of Amputation in Patients With Diabetes Mellitus and Peripheral Artery Disease
    Barnes, J. Aaron
    Eid, Mark A.
    Creager, Mark A.
    Goodney, Philip P.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2020, 40 (08) : 1808 - 1817
  • [4] Long-term outcomes of patients with diabetes mellitus undergoing percutaneous intervention for popliteal and infrapopliteal peripheral arterial disease
    Neupane, Saroj
    Edla, Sushruth
    Maidona, Eesha
    Sweet, Matthew C.
    Szpunar, Susan
    Davis, Thomas
    LaLonde, Thomas A.
    Mehta, Rajendra H.
    Rosman, Howard S.
    Yamasaki, Hiroshi
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2018, 92 (01) : 117 - 123
  • [5] Diabetes Mellitus and Peripheral Vascular Disease Diagnosis and Management
    Chin, Jason A.
    Sumpio, Bauer E.
    CLINICS IN PODIATRIC MEDICINE AND SURGERY, 2014, 31 (01) : 11 - +
  • [6] Diabetes Mellitus and Lower Extremity Peripheral Artery Disease
    Takahara, Mitsuyoshi
    JMA JOURNAL, 2021, 4 (03): : 225 - 231
  • [7] Sodium-glucose co-transporter 2 inhibitor use in patients with diabetes mellitus undergoing endovascular therapy for symptomatic peripheral artery disease
    Mitsuyoshi Takahara
    Yoshimitsu Soga
    Masahiko Fujihara
    Osamu Iida
    Daizo Kawasaki
    Cardiovascular Diabetology, 22
  • [8] Peripheral artery disease and disorders of microcirculation in patients with diabetes mellitus
    Dreyer, M.
    INTERNIST, 2011, 52 (05): : 533 - +
  • [9] Sodium-glucose co-transporter 2 inhibitor use in patients with diabetes mellitus undergoing endovascular therapy for symptomatic peripheral artery disease
    Takahara, Mitsuyoshi
    Soga, Yoshimitsu
    Fujihara, Masahiko
    Iida, Osamu
    Kawasaki, Daizo
    CARDIOVASCULAR DIABETOLOGY, 2023, 22 (01)
  • [10] Atherectomy for Infrainguinal Peripheral Artery Disease
    Garcia, Lawrence A.
    Lyden, Sean P.
    JOURNAL OF ENDOVASCULAR THERAPY, 2009, 16 : 105 - 115